AstraZeneca Immunotherapy Drug Earns FDA Approval

By | February 21, 2018

AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the FDA has approved Imfinzi for the treatment of certain patients with non-small cell lung cancer (NSCLC), specifically those with unresectable Stage III NSCLC whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy. Stage III (locally advanced) NSCLC is… Read More »

Career Workshop Smashes Previous Attendance Record!

By | February 13, 2018

Attendance at this year’s Student Career Workshop on January 27 obliterated all prior attendance records with over 110 participants!  We had a star-studded cast of presenters that included hiring managers from Pfizer and Alnylam, career counselors and industry professionals.  And we invited several young professionals who had attended prior Career Workshops to act as mentors… Read More »

Chapter Member Anniversaries: January 2018

By | February 6, 2018

Please congratulate the following members celebrating milestone anniversaries in January 2018.  Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Michael L. Anderson, Critical Process Systems Group Dr. Anthony C. Bevilacqua, Ph.D., Mettler-Toledo Thornton Inc Brian L. Clark, GMP Operations Consulting Andrew A. Coull, J.M. Coull, Inc. Daniel… Read More »

Welcome New Members!

By | February 6, 2018

We would like to introduce the members who joined ISPE in January 2018, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges.  And… Read More »

No Paper? No Problem! Lessons Learned Implementing Electronic Documentation

By | February 5, 2018

A critical aspect of any cGMP activity is documentation. As the old saying goes, “If it wasn’t written down, it didn’t happen.” But even as so many forms of communication have become electronic, paper-based documentation systems are still common among pharmaceutical companies. The simplicity of paper-based systems is seemingly obvious: all you need is a… Read More »

Boston Area and Delaware Valley Chapters Bet to Win

By | February 1, 2018

To make Sunday’s Super Bowl even more exciting, Boston Area Chapter President Jack Campion has thrown down the gauntlet and challenged Delaware Valley Chapter President Danielle Rebori to a friendly wager on the outcome: Whereas, the Boston Area Chapter encompasses a preponderance of New England Patriots fans AND Whereas, the Delaware Valley Chapter, in like… Read More »

Coming in Hot at Blazing Paddles

By | February 1, 2018

This month the Boston Area Chapter continued its annual tradition by welcoming the New Year at Blazing Paddles on Thursday, January 25. ISPE Members and guests brought their “A” game, competing in ping pong, networking and snacking on delicious appetizers. With multiple athletes playing in the tournaments, fellow colleagues and friends cheered them on, took… Read More »

Sanofi Acquires Bioverativ and Ablynx, Strengthens Position in Rare Blood Disorders

By | January 31, 2018

Sanofi’s acquisition of Ablynx in a deal valued at $4.8 billion complements the earlier acquisition of Biogen spin-off  Bioverativ for $11.6 billion. Both strengthen Sanofi’s position in rare blood disorders. Launched in 2017 following separation from Biogen, Bioverativ is focused on therapies for hemophilia and other rare blood disorders. With approximately $10 billion in annual… Read More »